Dividend declaration announcement
24/03/2009
Biocompatibles International plc announces that its Board of Directors has resolved to pay an interim dividend of 5 pence per ordinary share of 21 53/94 pence each in the share capital of the Company. The dividend, which is based on the royalty income from Abbott Laboratories on sales of Medtronic's Endeavor® Drug-Eluting Stent, is to be paid on 22 May 2009 to the holders of ordinary shares on the register at the close of business on 1 May 2009. The ex-dividend date is 29 April 2009.
Ends